Inhibition of Fatty Acid Metabolism Increases EPA and DHA Levels and Protects against Myocardial Ischaemia-Reperfusion Injury in Zucker Rats.


Journal

Oxidative medicine and cellular longevity
ISSN: 1942-0994
Titre abrégé: Oxid Med Cell Longev
Pays: United States
ID NLM: 101479826

Informations de publication

Date de publication:
2021
Historique:
received: 27 05 2021
accepted: 16 07 2021
entrez: 9 8 2021
pubmed: 10 8 2021
medline: 4 1 2022
Statut: epublish

Résumé

Long-chain

Identifiants

pubmed: 34367467
doi: 10.1155/2021/7493190
pmc: PMC8342141
doi:

Substances chimiques

Quaternary Ammonium Compounds 0
methyl-gamma-butyrobetaine 0
Docosahexaenoic Acids 25167-62-8
gamma-Aminobutyric Acid 56-12-2
Eicosapentaenoic Acid AAN7QOV9EA

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

7493190

Informations de copyright

Copyright © 2021 Janis Kuka et al.

Déclaration de conflit d'intérêts

JK, MMK, HC, SG, MD, and EL are listed as inventors in several international patent applications regarding the use of methyl-GBB for the treatment of cardiovascular and cardiometabolic diseases. None of the authors currently own any of these patents.

Références

Sci Rep. 2021 Apr 22;11(1):8781
pubmed: 33888830
Nutr Metab (Lond). 2016 Oct 4;13:65
pubmed: 27708685
Am J Clin Nutr. 2000 Oct;72(4):905-11
pubmed: 11010930
Biofactors. 2017 Sep 10;43(5):718-730
pubmed: 28759135
J Clin Med. 2020 Aug 19;9(9):
pubmed: 32824903
Am J Physiol Cell Physiol. 2015 Feb 15;308(4):C297-307
pubmed: 25472960
Nutr Res. 2019 Feb;62:1-12
pubmed: 30803501
Br J Pharmacol. 2015 Mar;172(5):1319-32
pubmed: 25363063
Am J Ther. 2016 May-Jun;23(3):e737-48
pubmed: 25036814
Cell Metab. 2012 May 2;15(5):595-605
pubmed: 22560212
Cardiovasc Res. 2018 Jun 1;114(7):925-927
pubmed: 29579150
Acta Pharmacol Sin. 2012 Feb;33(2):173-81
pubmed: 22301857
Eur J Pharmacol. 2011 May 11;658(2-3):277-83
pubmed: 21371472
Mol Cell Biochem. 2014 Oct;395(1-2):1-10
pubmed: 24878991
J Pharmacol Toxicol Methods. 2013 Mar-Apr;67(2):98-106
pubmed: 23202591
J Cardiovasc Pharmacol Ther. 2012 Jun;17(2):215-22
pubmed: 21903968
Mol Endocrinol. 1997 Jun;11(6):779-91
pubmed: 9171241
Vascul Pharmacol. 2015 Sep;72:101-7
pubmed: 25989106
Acta Physiol (Oxf). 2020 Mar;228(3):e13430
pubmed: 31840389
Am J Cardiol. 2004 Jan 15;93(2):136-41
pubmed: 14715336
Am J Physiol Heart Circ Physiol. 2008 Jul;295(1):H105-12
pubmed: 18469143
J Cell Mol Med. 2020 Jun;24(11):5937-5954
pubmed: 32384583
Circulation. 2009 Oct 20;120(16):1640-5
pubmed: 19805654
Biomolecules. 2015 Jun 29;5(3):1319-38
pubmed: 26131977
BMJ. 2013 Oct 22;347:f5934
pubmed: 24149519
Circulation. 2016 Aug 23;134(8):574-5
pubmed: 27550967
Br J Pharmacol. 2015 Jul;172(14):3461-71
pubmed: 26114403
Free Radic Biol Med. 2021 Mar;165:24-37
pubmed: 33484825
Free Radic Biol Med. 2021 Apr;166:33-52
pubmed: 33588049
Pharmacol Res. 2016 Nov;113(Pt B):788-795
pubmed: 26621248
Shock. 2019 Dec;52(6):e153-e162
pubmed: 30640252
Br J Pharmacol. 2010 Aug;160(7):1577-9
pubmed: 20649561
Cardiovasc Diabetol. 2016 Oct 28;15(1):149
pubmed: 27793156
Lancet Diabetes Endocrinol. 2020 Nov;8(11):915-930
pubmed: 32949497
Life Sci. 2014 Nov 24;118(2):173-8
pubmed: 24792520
Basic Clin Pharmacol Toxicol. 2017 Aug;121(2):106-112
pubmed: 28244203
Expert Opin Ther Targets. 2021 Jun 21;:1-8
pubmed: 34128755
N Engl J Med. 2011 Nov 24;365(21):1969-79
pubmed: 22082239
Biochem J. 2016 May 1;473(9):1191-202
pubmed: 26936967
Br J Pharmacol. 2010 Aug;160(7):1573-6
pubmed: 20649560
Biomed Pharmacother. 2021 Jan;133:110970
pubmed: 33166763
Lipids Health Dis. 2015 Dec 15;14:163
pubmed: 26666303
FASEB J. 2013 Oct;27(10):3966-78
pubmed: 23825227
Am Heart J. 1994 Apr;127(4 Pt 1):744-55
pubmed: 8154411
Circ Res. 2017 Apr 28;120(9):1477-1486
pubmed: 28450365
Can J Diabetes. 2014 Dec;38(6):461-5
pubmed: 25219961
Sci Rep. 2016 Jul 21;6:30111
pubmed: 27439777
Circulation. 2005 Oct 25;112(17):2735-52
pubmed: 16157765
Prostaglandins Leukot Essent Fatty Acids. 2016 Aug;111:11-6
pubmed: 27499449
ESC Heart Fail. 2021 Jun;8(3):1966-1978
pubmed: 33665922
J Diabetes. 2017 Oct;9(10):936-946
pubmed: 27860326

Auteurs

Janis Kuka (J)

Latvian Institute of Organic Synthesis, Laboratory of Pharmaceutical Pharmacology, Riga, Latvia.

Marina Makrecka-Kuka (M)

Latvian Institute of Organic Synthesis, Laboratory of Pharmaceutical Pharmacology, Riga, Latvia.

Karlis Vilks (K)

Latvian Institute of Organic Synthesis, Laboratory of Pharmaceutical Pharmacology, Riga, Latvia.
University of Latvia, Faculty of Biology, Riga, Latvia.

Stanislava Korzh (S)

Latvian Institute of Organic Synthesis, Laboratory of Pharmaceutical Pharmacology, Riga, Latvia.

Helena Cirule (H)

Latvian Institute of Organic Synthesis, Laboratory of Pharmaceutical Pharmacology, Riga, Latvia.

Eduards Sevostjanovs (E)

Latvian Institute of Organic Synthesis, Laboratory of Pharmaceutical Pharmacology, Riga, Latvia.

Solveiga Grinberga (S)

Latvian Institute of Organic Synthesis, Laboratory of Pharmaceutical Pharmacology, Riga, Latvia.

Maija Dambrova (M)

Latvian Institute of Organic Synthesis, Laboratory of Pharmaceutical Pharmacology, Riga, Latvia.
Riga Stradins University, Faculty of Pharmacy, Riga, Latvia.

Edgars Liepinsh (E)

Latvian Institute of Organic Synthesis, Laboratory of Pharmaceutical Pharmacology, Riga, Latvia.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH